ArticleInternational journal of medical sciences2024

Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression.

Ching-Han Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.